AJC -
May 20, 2020
COVID-19 News from Around the Web
AJC -
May 20, 2020
The Christian Post -
May 20, 2020
NPR -
May 20, 2020
President Trump is giving the World Health Organization 30 days to commit to substantial changes in how it operates — or he will make his hold on U.S. funding permanent. The threat came in a letter that sharply criticizes the WHO response to the COVID-19 pandemic and its relationship with China. "The World Health Organization has repeatedly made claims about the coronavirus that were either grossly inaccurate or misleading," Trump wrote in the four-page letter to WHO Director-General Tedros Adhanom Ghebreyesus.
AP -
May 20, 2020
Beyond the hot spots of Brazil and Mexico, the coronavirus is threatening to overwhelm Latin American cities large and small in an alarming sign that the pandemic may be only at the start of its destructive march through the region. More than 90% of intensive care beds were full last week in Chile’s capital, Santiago, whose main cemetery dug 1,000 emergency graves to prepare for a wave of deaths. In Lima, Peru, patients took up 80% of intensive care beds as of Friday. Peru has the world’s 12th-highest number of confirmed cases, with more than 90,000.
STAT -
May 20, 2020
Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects. The company’s stock valuation also surged, hitting $29 billion, an astonishing feat for a company that currently sells zero products. But was there good reason for so much enthusiasm? Several vaccine experts asked by STAT concluded that, based on the information made available by the Cambridge, Mass.-based company, there’s really no way to know how impressive — or not — the vaccine may be.
The Augusta Chronicle -
May 19, 2020
AJC -
May 19, 2020
WSBTV -
May 19, 2020
WSBTV -
May 19, 2020
Athens Banner-Herald -
May 19, 2020
AJC -
May 19, 2020
CNN -
May 19, 2020
President Donald Trump late Monday threatened to permanently pull US funding from the World Health Organization if it does not "commit to major substantive improvements in the next 30 days." In a letter to WHO Director-General Tedros Adhanom Ghebreyesus, Trump said, "It is clear the repeated missteps by you and your organization in responding to the pandemic have been extremely costly for the world. The only way forward for the World Health Organization is if it can actually demonstrate independence from China.” The threat is more proof of Trump's instinct to distrust global institutions at a time when many of his predecessors would rely on such relationships to help stem the tide of a pandemic.
AP -
May 19, 2020
President Donald Trump said Monday that he is taking a malaria drug to protect against the coronavirus, despite warnings from his own government that it should only be administered for COVID-19 in a hospital or research setting due to potentially fatal side effects. Trump told reporters he has been taking the drug, hydroxychloroquine, and a zinc supplement daily “for about a week and a half now.” Trump spent weeks pushing the drug as a potential cure or prophylaxis for COVID-19 against the cautionary advice of many of his administration’s top medical professionals. The drug has the potential to cause significant side effects in some patients and has not been shown to combat the new coronavirus. Trump said his doctor did not recommend the drug to him, but he requested it from the White House physician.
AP -
May 19, 2020
An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers. Study volunteers given either a low or medium dose of the vaccine by Cambridge, Massachusetts-based Moderna Inc. had antibodies similar to those seen in people who have recovered from COVID-19. In all, 45 people have received one or two shots of the vaccine, which was being tested at three different doses. The kind of detailed antibody results needed to assess responses are only available on eight volunteers so far. The vaccine seems safe, the company said, but much more extensive testing is needed to see if it remains so. A high dose version is being dropped after spurring some short-term side effects.
AJC -
May 18, 2020